Instructions to Reviewer:

As an independent reviewer for the UW-Madison ICEP, your role is to ensure that the educational content in the education is fair and balanced, and that any clinical content presented supports safe, effective patient care.

Review the attached educational materials in order to confirm that:

1. All recommendations for patient care are based on current science, evidence, and clinical reasoning.
2. All recommendations present a fair and balanced view of diagnostic and therapeutic options.
3. All scientific research referred to, reported, or used in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation.
4. New and evolving topics for which there is a lower (or absent) evidence base are clearly identified as such within the education and individual presentations.
5. The faculty does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning.
6. The faculty does not advocate for, or promote, unscientific approaches to diagnosis or therapy, or recommendations, treatment or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
7. Overall, the content is designed to be free of commercial or other types of bias.
   1. Content does NOT contain any marketing produced by or for an ineligible company,* including corporate or product logos, trade names or product group messages.  Generic or scientific names of medications and medical devices are used wherever possible and practical to promote impartiality. If a trade name of a medication/device is used, the first reference for all medications/devices discussed in the activity should include the generic name together with the trade name, and subsequent references should use only the generic name.
8. The UW-Madison ICEP Chair is the final arbiter of whether the disclosed conflicts of interest have been resolved.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

After carefully reviewing the podcast episode and or/other educational materials and considering the relationship(s) speakers, planners and hosts have with ineligible companies, answer the questions below.  Please provide a thorough explanation when requested.